featured
Short-Duration Pan-Genotypic Therapy With Glecaprevir/Pibrentasvir for Patients With Recent HCV Infection
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Hepatology (Baltimore, Md.)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Short-Duration Pan-Genotypic Therapy With Glecaprevir/Pibrentasvir for 6 Weeks Among People With Recent Hepatitis C Viral Infection
Hepatology 2020 Jul 01;72(1)7-18, M Martinello, C Orkin, G Cooke, S Bhagani, E Gane, R Kulasegaram, D Shaw, E Tu, K Petoumenos, P Marks, J Grebely, GJ Dore, M Nelson, GV MatthewsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.